文献速递乳腺乳腺X线

在大型筛查人群中合成二维乳腺摄影联合断层摄影的临床性能

Clinical Performance of Synthesized Two-dimensional Mammography Combined with Tomosynthesis in a Large Screening Population.
PubMed 文献 · Radiology · 2017-02-21

该回顾性研究比较了78 810例筛查乳腺摄影中FFDM、DBT-FFDM与DBT-s2D三种方案的召回率、阳性预测值和癌症检出率。DBT-s2D的召回率显著低于DBT-FFDM和FFDM,癌症检出率三组相似无显著差异,DBT-s2D的浸润性癌比例和阳性预测值显著高于DBT-FFDM。

要点

  • DBT-s2D召回率4.3%,显著低于DBT-FFDM的5.8%和FFDM的8.7%。
  • 癌症检出率FFDM 5.3/1000、DBT-FFDM 6.4/1000、DBT-s2D 6.1/1000,无显著差异。
  • DBT-s2D阳性预测值40.8%,显著高于DBT-FFDM的28.5%。

核心结论

  • 在大型社区筛查实践中,与DBT-FFDM和单独FFDM相比,DBT-s2D筛查提高了召回率和阳性预测值,且未损失癌症检出率。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并符合HIPAA要求,豁免知情同意;共收集2011年10月11日至2016年6月30日78 810例筛查乳腺摄影,其中FFDM 32 076例、DBT-FFDM 30 561例、DBT-s2D 16 173例。

诊断标准与关键数值

  • 召回率:DBT-s2D 4.3%(687/16 173)vs DBT-FFDM 5.8%(1785/30 561),OR 0.72(95%CI 0.65, 0.78),P < .0001;DBT-s2D vs FFDM 8.7%(2799/32 076),OR 0.46(95%CI 0.43, 0.51)。
  • 癌症检出率:FFDM 5.3/1000筛查 vs DBT-FFDM 6.4/1000筛查,P = .08;FFDM vs DBT-s2D 6.1/1000筛查,P = .27,无显著差异。
  • 浸润性癌检出比例:DBT-s2D 76.5% vs DBT-FFDM 61.3%,P = .01。
  • 阳性预测值:DBT-s2D 40.8% vs DBT-FFDM 28.5%,P < .0001。

临床应用与阅片要点

  • 在社区筛查人群中,DBT-s2D方案可降低召回率并提高阳性预测值,同时保持癌症检出率。
  • DBT-s2D的浸润性癌检出比例高于DBT-FFDM,提示其检出的癌症更具临床意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare the clinical performance of synthesized two-dimensional (s2D) mammography combined with digital breast tomosynthesis (DBT) with that of full-field digital mammography (FFDM) alone and FFDM combined with DBT in a large community-based screening population by analyzing recall rate, positive predictive value, and cancer detection rate. Materials and Methods This was a retrospective study approved by the institutional review board and was HIPAA compliant with waiver of informed consent. A total of 78 810 screening mammograms from October 11, 2011, to June 30, 2016, were retrospectively collected. Of these, 32 076 were FFDM, 30 561 were DBT-FFDM, and 16 173 were DBT-s2D mammograms. Diagnostic performance of FFDM, DBT-FFDM, and DBT-s2D mammography was compared. Statistical significance was determined by using the Pearson χ2 test and was expressed as odds ratios and related confidence intervals determined by means of logistic regression analysis with pairwise comparisons. Results Recall rates were significantly lower with DBT-s2D mammography (4.3%, 687 of 16 173) when compared with DBT-FFDM (5.8%, 1785 of 30 561; odds ratio, 0.72; 95% confidence interval: 0.65, 0.78; P < .0001) and when compared with FFDM alone (8.7%, 2799 of 32 076; odds ratio, 0.46; 95% confidence interval: 0.43, 0.51). The cancer detection rate was similar among FFDM alone (5.3 of 1000 screening examinations), DBT-FFDM (6.4 of 1000 screening examinations), and DBT-s2D mammography (6.1 of 1000 screening examinations) with no significant difference (FFDM vs DBT-FFDM, P = .08; FFDM vs DBT-s2D, P = .27). The percentage of invasive cancers detected was significantly higher with DBT-s2D mammography (76.5%) than with DBT-FFDM (61.3%, P = .01), and positive predictive values with DBT-s2D mammography (40.8%) were significantly higher than those with DBT-FFDM (28.5%, P < .0001). Conclusion Screening with DBT-s2D mammography in a large community-based practice improved recall rate and positive predictive values without loss of cancer detection rate when compared with DBT-FFDM and FFDM alone. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Aujero MP, Gavenonis SC, Benjamin R, et al. Clinical Performance of Synthesized Two-dimensional Mammography Combined with Tomosynthesis in a Large Screening Population. Radiology. 2017. PMID: 28221096. doi:10.1148/radiol.2017162674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。